Pediatric hepatic cancer incidence and survival: 30-year trends in Ontario, Canada; the United States; and Australia

被引:6
作者
Di Giuseppe, Giancarlo [1 ,2 ]
Youlden, Danny R. [3 ,4 ]
Aitken, Joanne F. [3 ,4 ,5 ]
Pole, Jason D. [1 ,2 ,6 ]
机构
[1] Pediat Oncol Grp Ontario, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Canc Council Queensland, Brisbane, Qld, Australia
[4] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia
[5] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia
[6] Univ Queensland, Ctr Hlth Serv Res, Brisbane, Qld, Australia
关键词
Australia; childhood hepatic cancer; epidemiology; incidence; North America; retrospective cohort; survival; POPULATION-BASED REGISTRIES; CHILDHOOD-CANCER; GLOBAL SURVEILLANCE; LIVER; EPIDEMIOLOGY; STATISTICS; CHILDREN; LESSONS; IMPACT;
D O I
10.1002/cncr.33319
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Pediatric hepatic cancer is a rare malignancy, comprising only approximately 2% of all cancers diagnosed in children aged <15 years. The authors sought to describe trends in pediatric hepatic cancer incidence and survival in Ontario, Canada; the United States; and Australia. Methods Children aged <15 years who were diagnosed with hepatic cancer from 1985 through 2013 were ascertained through population-based registries and followed from the time of diagnosis until December 31, 2015. Age-standardized incidence and 5-year relative survival were calculated for each jurisdiction. Multivariable flexible parametric survival models were used to explore predictors of hepatic cancer mortality. Results A total of 794 children were identified in Ontario (148 children), the United States (400 children), and Australia (246 children). The average annual incidence increased by 2.2% (95% CI, 0.5%-4.0%) in Australia, 2.1% (95% CI, 0.9%-3.3%) in the United States, and 1.3% (95% CI, -0.4% to 3.0%) in Ontario. The 5-year relative survival rate improved from 60% to 82% (P = .08) in Ontario and 62% to 78% (P = .02) in the United States between the diagnostic periods 1985 through 1994 and 2005 through 2013, whereas in Australia the rate remained constant (between 74% and 77%) during the study period. On multivariable analysis, there was no significant difference noted with regard to the hazard of death between jurisdictions (P = .06). Older age, the presence of metastatic disease, and being diagnosed with hepatocellular carcinoma were found to be associated with mortality. Conclusions The incidence of hepatic cancer in children appears to have increased over the last 30 years in Australia and North America. Survival differences between Australia; Ontario, Canada; and the United States observed in the 1980s and 1990s were no longer apparent and only marginal geographical differences in the hazard of mortality were observed.
引用
收藏
页码:769 / 776
页数:8
相关论文
共 43 条
[1]  
Ahmad OB, 2001, GPE DISCUSSION PAPER, V31
[2]   Predictors of survival and incidence of hepatoblastoma in the paediatric population [J].
Allan, Bassan J. ;
Parikh, Punam P. ;
Diaz, Sofia ;
Perez, Eduardo A. ;
Neville, Holly L. ;
Sola, Juan E. .
HPB, 2013, 15 (10) :741-746
[3]   Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].
Allemani, Claudia ;
Matsuda, Tomohiro ;
Di Carlo, Veronica ;
Harewood, Rhea ;
Matz, Melissa ;
Niksic, Maja ;
Bonaventure, Audrey ;
Valkov, Mikhail ;
Johnson, Christopher J. ;
Esteve, Jacques ;
Ogunbiyi, Olufemi J. ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Eser, Sultan ;
Engholm, Gerda ;
Stiller, Charles A. ;
Monnereau, Alain ;
Woods, Ryan R. ;
Visser, Otto ;
Lim, Gek Hsiang ;
Aitken, Joanne ;
Weir, Hannah K. ;
Coleman, Michel P. .
LANCET, 2018, 391 (10125) :1023-1075
[4]   Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) [J].
Allemani, Claudia ;
Weir, Hannah K. ;
Carreira, Helena ;
Harewood, Rhea ;
Spika, Devon ;
Wang, Xiao-Si ;
Bannon, Finian ;
Ahn, Jane V. ;
Johnson, Christopher J. ;
Bonaventure, Audrey ;
Marcos-Gragera, Rafael ;
Stiller, Charles ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Ogunbiyi, Olufemi J. ;
Rachet, Bernard ;
Soeberg, Matthew J. ;
You, Hui ;
Matsuda, Tomohiro ;
Bielska-Lasota, Magdalena ;
Storm, Hans ;
Tucker, Thomas C. ;
Coleman, Michel P. .
LANCET, 2015, 385 (9972) :977-1010
[5]   Hepatocellular carcinoma in children: hepatic resection and liver transplantation [J].
Angelico, Roberta ;
Grimaldi, Chiara ;
Saffioti, Maria Cristina ;
Castellano, Aurora ;
Spada, Marco .
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
[6]  
[Anonymous], 2016, Australian Demographic Statistics
[7]   Global trends in the burden of liver cancer [J].
Are, Chandrakanth ;
Meyer, Bria ;
Stack, Apollo ;
Ahmad, Humera ;
Smith, Lynette ;
Qian, Biyun ;
Song, Tianqiang ;
Chowdhury, Sanjib .
JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (05) :591-602
[8]   Malignant tumors of the liver in children [J].
Aronson, Daniel C. ;
Meyers, Rebecka L. .
SEMINARS IN PEDIATRIC SURGERY, 2016, 25 (05) :265-275
[9]  
Australian Institute of Health and Welfare, 2020, GEN REC INC MORT GRI
[10]   Childhood cancer burden: a review of global estimates [J].
Bhakta, Nickhill ;
Force, Lisa M. ;
Allemani, Claudia ;
Atun, Rifat ;
Bray, Freddie ;
Coleman, Michel P. ;
Steliarova-Foucher, Eva ;
Frazier, A. Lindsay ;
Robison, Leslie L. ;
Rodriguez-Galindo, Carlos ;
Fitzmaurice, Christina .
LANCET ONCOLOGY, 2019, 20 (01) :E42-E53